Cargando…
American Epilepsy Society (AES): Written Comments to Norman E. “Ned” Sharpless, MD, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N-1482, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments: Submitted on: July 16, 2019
Autores principales: | Welty, Timothy E., Chapman, Kevin E., Faught, R. Edward, Kotloski, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891184/ https://www.ncbi.nlm.nih.gov/pubmed/31640419 http://dx.doi.org/10.1177/1535759719878716 |
Ejemplares similares
-
Paxlovid(TM) Information From FDA and Guidance for AES
Members
por: Cokley, Jon A., et al.
Publicado: (2022) -
FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory From the Ad Hoc ILAE/AES Task Force
por: French, Jacqueline A., et al.
Publicado: (2021) -
Food Equivalents
Publicado: (1874) -
FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019) -
2019 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Shaer, Danah, et al.
Publicado: (2020)